期刊
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 115, 期 -, 页码 426-437出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2016.03.041
关键词
MRSA; Metronidazole; PBP2a; Oxacillin; Triazole; Methicillin; Oxacillin
资金
- SERB-Department of Science and Technology New Delhi, India [EMR/2014/001127]
- CSIR
MRSA causes 60-70% of Staphylococcus aureus infection in hospitals and it has developed resistance against the currently available drugs. Interestingly, a series of 35 metronidazole-triazole hybrids on screening against MRSA were found to be active. Compound 22 was found to be effective at 4 mu g/mL concentration against nine strains of MRSA. The inhibitory activity was further enhanced upto 1 mu g/mL when this compound was used in combination with oxacillin in 1:1 ratio. All the compounds were found to be non-toxic in THP-1 cell line upto a concentration of 50 mu M. The time-kill kinetics studies suggested bacteriostatic nature of the compounds. In silico studies show that these compounds interact with Thr600, Ser598, Asn464, His583 and Tyr446 in the active site of PBP2a crystal structure from MRSA. (C) 2016 Elsevier Masson SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据